Showing results (21-30 of 43) with videos related to

Sort By:
Pageof 5
Annals of the Rheumatic Diseases|January 24, 2012
The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritisDirk Holzinger, Michael Frosch, Astrid Kastrup, et al.
The Journal of Rheumatology|January 17, 2018
S100A12 Is Associated with Response to Therapy in Juvenile Idiopathic ArthritisFaekah Gohar, Janneke Anink, Halima Moncrieffe, et al.
Lupus|March 4, 2021
Nailfold capillary abnormalities in childhood-onset systemic lupus erythematosus: a cross-sectional study compared with healthy controlsDieneke Schonenberg-Meinema, Sandy C Bergkamp, Amara Nassar-Sheikh Rashid, et al.
Pediatric Rheumatology Online Journal|May 24, 2019
The PRINTO evidence-based proposal for glucocorticoids tapering/discontinuation in new onset juvenile dermatomyositis patientsGabriella Giancane, Claudio Lavarello, Angela Pistorio, et al.
Pediatric Rheumatology Online Journal|May 10, 2024
Increasing the etanercept dose in a treat-to-target approach in juvenile idiopathic arthritis: does it help to reach the target? A post-hoc analysis of the BeSt for Kids randomised clinical trialBastiaan T van Dijk, Sytske Anne Bergstra, J Merlijn van den Berg, et al.
Pediatric Rheumatology Online Journal|August 26, 2023
Significant pain decrease in children with non-systemic Juvenile Idiopathic Arthritis treated to target: results over 24 months of follow upKatinka Spekking, Janneke Anink, Piroska de Boer, et al.
RMD Open|March 17, 2023
Patterns of clinical joint inflammation in juvenile idiopathic arthritisSascha L Heckert, Petra C E Hissink-Muller, J Merlijn van den Berg, et al.
JAMA|November 8, 2011
Factors associated with treatment response to etanercept in juvenile idiopathic arthritisMarieke H Otten, Femke H M Prince, Wineke Armbrust, et al.
Annals of the Rheumatic Diseases|May 11, 2007
Long-term outcome of juvenile idiopathic arthritis following a placebo-controlled trial: sustained benefits of early sulfasalazine treatmentMarion A J van Rossum, Renée M van Soesbergen, Maarten Boers, et al.
The Journal of Rheumatology|August 17, 2011
Tumor necrosis factor-blocking agents for children with enthesitis-related arthritis--data from the dutch arthritis and biologicals in children register, 1999-2010Marieke H Otten, Femke H M Prince, Marinka Twilt, et al.
Pageof 5